3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
59
Unknown
19
Terminated
18
Withdrawn
10
Recruiting
5
Not yet recruiting
3
Suspended
1
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Neoplasms
40
Breast Neoplasms
40
Prostatic Neoplasms
24
Colorectal Neoplasms
24
Uterine Cervical Neoplasms
16
Carcinoma, Non-Small-Cell Lung
14
Anxiety Disorders
13
Stomach Neoplasms
9
Lymphoma, Follicular
9
Lung Neoplasms
9
Leukemia, Myeloid, Acute
9
Carcinoma, Hepatocellular
8
Brain Neoplasms
8
Urinary Bladder Neoplasms
7
Sarcoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Esophageal Squamous Cell Carcinoma
7
Esophageal Neoplasms
7
Ovarian Neoplasms
6
Epilepsy
6
Depression
6
Colonic Neoplasms
6
Uterine Cervical Dysplasia
5
Small Cell Lung Carcinoma
5
Pain
5
Glioma
5
Dementia
5
Cholangiocarcinoma
5
Recurrence
4
Interventions
Alginates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Interventional
×
Mucositis
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled